Research Progress on Chinese Medicine Immunomodulatory Intervention for Chronic Primary Immune Thrombocytopenia: Targeting Cellular Immunity.
Chronic primary immune thrombocytopenia (CITP) is the most common acquired autoimmune disease that seriously threaten the physical and mental health of patients. Compared with Western medicine treatment, the intervention and treatment of Chinese medicine (CM) has shown certain therapeutic advantages. This paper reviewed the new pathogenesis progress on T cell immune abnormality in CITP, and CM studies on interferes effects of cellular immune regulation of CITP in recent years. Qi deficiency failing to control blood and internal obstruction of blood stasis are the two common types of CM syndromes in CITP patients, the corresponding treatments include invigorating Pi (Spleen), supplementing qi, activating blood, as well as tonifying qi and activating yang, regulating Gan (Liver) to invigorate Pi. The authors also mentioned the problems in the research field of CM for CTIP treatment, and put forward new ideas for the research in the future.
['Liu|Wen-Bin|WB|', 'Li|Sai|S|', 'Yu|Xiao-Ling|XL|', 'Dai|Tie-Ying|TY|', 'Gao|Rui-Lan|RL|']
D004365:Drugs, Chinese Herbal D006470:Hemorrhage D006801:Humans D007111:Immunity, Cellular D016553:Purpura, Thrombocytopenic, Idiopathic D012106:Research
Chinese medicine cellular immunity chronic immune thrombocytopenia